81 related articles for article (PubMed ID: 24203942)
1. Moving ahead with personalized mouse models.
Bender E
Cancer Discov; 2013 Nov; 3(11):1214. PubMed ID: 24203942
[No Abstract] [Full Text] [Related]
2. What's Next for Patient-Derived Xenograft Modeling?
Gritters J
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982758
[No Abstract] [Full Text] [Related]
3. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.
Rubio-Viqueira B; Hidalgo M
Clin Pharmacol Ther; 2009 Feb; 85(2):217-21. PubMed ID: 19005462
[No Abstract] [Full Text] [Related]
4. Patient-derived tumor xenograft models in drug development.
Hidalgo M
Clin Adv Hematol Oncol; 2017 Nov; 15(11):844-846. PubMed ID: 29200416
[No Abstract] [Full Text] [Related]
5. PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity.
Zhang CC; Yan Z; Zhang Q; Kuszpit K; Zasadny K; Qiu M; Painter CL; Wong A; Kraynov E; Arango ME; Mehta PP; Popoff I; Casperson GF; Los G; Bender S; Anderes K; Christensen JG; VanArsdale T
Clin Cancer Res; 2010 Nov; 16(21):5177-88. PubMed ID: 20829331
[TBL] [Abstract][Full Text] [Related]
6. The challenge of selecting the 'right' in vivo oncology pharmacology model.
Firestone B
Curr Opin Pharmacol; 2010 Aug; 10(4):391-6. PubMed ID: 20634135
[TBL] [Abstract][Full Text] [Related]
7. From human to mouse and back: 'tumorgraft' models surge in popularity.
Garber K
J Natl Cancer Inst; 2009 Jan; 101(1):6-8. PubMed ID: 19116380
[No Abstract] [Full Text] [Related]
8. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
9. In vivo target validation by inducible RNAi in human xenograft mouse models.
Mazzoletti M; Texidó G
Methods Mol Biol; 2013; 986():325-37. PubMed ID: 23436421
[TBL] [Abstract][Full Text] [Related]
10. Catch of the day: zebrafish as a human cancer model.
Stoletov K; Klemke R
Oncogene; 2008 Jul; 27(33):4509-20. PubMed ID: 18372910
[TBL] [Abstract][Full Text] [Related]
11. Genetically engineered animal models for in vivo target identification and validation in oncology.
Texidó G
Methods Mol Biol; 2013; 986():281-305. PubMed ID: 23436419
[TBL] [Abstract][Full Text] [Related]
12. Creation and characterization of a xenograft model for human cervical cancer.
Hoffmann C; Bachran C; Stanke J; Elezkurtaj S; Kaufmann AM; Fuchs H; Loddenkemper C; Schneider A; Cichon G
Gynecol Oncol; 2010 Jul; 118(1):76-80. PubMed ID: 20441999
[TBL] [Abstract][Full Text] [Related]
13. RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response.
Yin X; Luistro L; Zhong H; Smith M; Nevins T; Schostack K; Hilton H; Lin TA; Truitt T; Biondi D; Wang X; Packman K; Rosinski J; Berkofsky-Fessler W; Tang JP; Pant S; Geho D; Vega-Harring S; Demario M; Levitsky H; Simcox M
Clin Cancer Res; 2013 Oct; 19(20):5686-98. PubMed ID: 23974006
[TBL] [Abstract][Full Text] [Related]
14. Contributions of human tumor xenografts to anticancer drug development.
Sausville EA; Burger AM
Cancer Res; 2006 Apr; 66(7):3351-4, discussion 3354. PubMed ID: 16585151
[TBL] [Abstract][Full Text] [Related]
15. The chimeric human/mouse model of angiogenesis.
Petitclerc E; von Schalscha T; Brooks PC
Methods Mol Biol; 2000; 137():213-21. PubMed ID: 10948540
[No Abstract] [Full Text] [Related]
16. Cancer: off by a whisker.
Dennis C
Nature; 2006 Aug; 442(7104):739-41. PubMed ID: 16915261
[No Abstract] [Full Text] [Related]
17. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Merk J; Rolff J; Becker M; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
[TBL] [Abstract][Full Text] [Related]
18. Athymic nude mice as an experimental model for cancer treatment.
Szadvari I; Krizanova O; Babula P
Physiol Res; 2016 Dec; 65(Suppl 4):S441-S453. PubMed ID: 28006926
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of kigamicin D on mouse tumor models.
Masuda T; Ohba S; Kawada M; Osono M; Ikeda D; Esumi H; Kunimoto S
J Antibiot (Tokyo); 2006 Apr; 59(4):209-14. PubMed ID: 16830887
[TBL] [Abstract][Full Text] [Related]
20. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
